496 related articles for article (PubMed ID: 25281418)
1. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
[TBL] [Abstract][Full Text] [Related]
2. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
3. Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.
Xue X; Feng T; Yao S; Wolf KJ; Liu CG; Liu X; Elson CO; Cong Y
J Immunol; 2011 Dec; 187(11):5879-86. PubMed ID: 22068236
[TBL] [Abstract][Full Text] [Related]
4. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
5. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.
Shi Y; Dai S; Qiu C; Wang T; Zhou Y; Xue C; Yao J; Xu Y
Mucosal Immunol; 2020 Mar; 13(2):303-312. PubMed ID: 31628427
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
[TBL] [Abstract][Full Text] [Related]
8. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
[TBL] [Abstract][Full Text] [Related]
10. Critical role of ROCK2 activity in facilitating mucosal CD4
Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
[TBL] [Abstract][Full Text] [Related]
11. miR-340 affects sauchinone inhibition of Th17 cell differentiation and promotes intestinal inflammation in inflammatory bowel disease.
Chen Q; He Q; Xiu W; Chen Y; Guo Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1157-1163. PubMed ID: 32321642
[TBL] [Abstract][Full Text] [Related]
12. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
15. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis.
Zhou J; Lai W; Yang W; Pan J; Shen H; Cai Y; Yang C; Ma N; Zhang Y; Zhang R; Xie X; Dong Z; Gao Y; Du C
Cell Mol Immunol; 2018 Dec; 15(12):1047-1056. PubMed ID: 29670278
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
[TBL] [Abstract][Full Text] [Related]
17. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
18. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function.
Dudeck A; Suender CA; Kostka SL; von Stebut E; Maurer M
Eur J Immunol; 2011 Jul; 41(7):1883-93. PubMed ID: 21491417
[TBL] [Abstract][Full Text] [Related]
19. Anti-IL-23 receptor monoclonal antibody prevents CD4
Imamura E; Taguchi K; Sasaki-Iwaoka H; Kubo S; Furukawa S; Morokata T
Eur J Pharmacol; 2018 Apr; 824():163-169. PubMed ID: 29391156
[TBL] [Abstract][Full Text] [Related]
20. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
